Sughrue Mion, PLLC
Chimera protein comprising FVIII and vWF factors, and use thereof
A chimera protein according to the present application has a significantly increased in vivo half-life when administered because of a vWF domain coupled to FVIII, such that when used as a hemophilia A therapeutic agent, convenience for patients can be increased and medical expenses can be reduced.
MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH
A C C C C A C C A
A61P C07K C07K C12N C07K A61K C07K C12N A61P
inventional additional inventional inventional additional additional additional inventional inventional
So Ra Yong Jae Eui-Cheol Jae Hwan Mee Sook Jin-hyun Seung-Hoon Injae
Kim Kim Jo Ryu Oh Park Lee Oh